17:32 EST Tourmaline Bio (TRML) files $350M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TRML: Tourmaline Bio reports Q3 EPS (78c), consensus (82c) Keros Therapeutics appoints Chyung as CMO Tourmaline Bio initiated with an Overweight at Cantor Fitzgerald Tourmaline Bio to host webinar on human genetic validation for IL-6 inhibition Tourmaline Bio management to meet with Truist Disclaimer & DisclosureReport an Issue
